Membranous glomerulonephritis epidemiology and demographics

Membranous glomerulonephritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Membranous glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
Ultrasound
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Membranous glomerulonephritis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Membranous glomerulonephritis epidemiology and demographics
CDC on Membranous glomerulonephritis epidemiology and demographics
Membranous glomerulonephritis epidemiology and demographics in the news
Blogs on Membranous glomerulonephritis epidemiology and demographics
Directions to Hospitals Treating Membranous glomerulonephritis
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Epidemiology and Demographics

Incidence

• The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

• The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

• In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a case-fatality rate/mortality rate of 0.38%.
• The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38%

Age

• Patients of all age groups may develop membranous glomerulonephritis.
• The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years.
• Membranous Glomerulonephritis commonly affects individuals older than 40 years of age.

Race

• membranous glomerulopathy usually affects individuals of the caucasian race.

Gender

• Membranous glomerulonephritis affects men and women equally.

Region

• Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.